SCHEMBL9893259

SCHEMBL9893259

O=C(O)c1nc2ccc(C(F)(F)F)cn2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.43
GABRD O14764 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRA4 P48169 1/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TRPA1 O75762 3/20 0.41
SLC2A1 P11166 1/20 0.40
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
KDM4E B2RXH2 4/20 0.37
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
GFER P55789 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
RCE1 Q9Y256 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9893241 0.82 USP7 (0.43) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL9925354 0.80 MAPT (0.45) TRPA1PTGS1PTGS2KDM4ENPC1
SCHEMBL9893273 0.79 GABRD (0.45) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL18131813 0.78 USP7 (0.44) USP7ALDH1A1SMN1; SMN2TRPA1PTGS1
SCHEMBL29181625 0.78 SMN1; SMN2 (0.48) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL9923914 0.77 KDM4E (0.51) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL25028838 0.77 USP7 (0.39) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL19711945 0.76 TRPA1 (0.39) USP7GABRDGABRB1GABRA4ALDH1A1
SCHEMBL25326583 0.75 SMN1; SMN2 (0.46) USP7GABRDGABRB1GABRA4ALDH1A1
Hydrochloric Acid SCHEMBL19712038 0.75 TRPA1 (0.38) USP7GABRDGABRB1GABRA4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-9067935-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2015-06-30 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2014-03-27 US disclosed
US-8618150-B2 Imidazo[1,2-α]pyridine sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2013-12-31 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, NV (BE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149699-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 USP7 4626/4885GABRD 2142/4885GABRB1 843/4885
US-20140088098-A1 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPV1, TRPM2 USP7 4626/4885GABRD 2142/4885GABRB1 843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.